A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment

Tactile Medical

Status: Completed

Conditions: Head and Neck Neoplasms; Head and Neck Cancer; Head and Neck Lymphedema

Treatments: Other: Standard home lymphedema care; Device: Flexitouch head and neck lymphedema treatment system

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03332160

4030

Details and patient eligibility

About

The study will evaluate the feasibility and potential effectiveness of the Flexitouch head and neck treatment plus standard home care compared to standard home care regimen alone.

Full description

This study is an open-label, multi-site, stratified randomized, wait list control, pilot study. The study will be conducted at up to 2 sites in the United States and enroll 40 subjects with a diagnosis of head and neck lymphedema following treatment for head and neck cancer. Subjects randomized to receive daily treatment with the Flexitouch pneumatic compression device and home care regimen (SOC) will be seen at baseline and weeks 1, 4, and 8. Subjects randomized to the wait list arm will be seen at baseline and weeks 1, 4, and 8 while receiving SOC treatment. Assessments will include fidelity, satisfaction, symptoms, swelling/inflammation, function, and QOL.

Enrollment: 49 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years.
• A previous diagnosis of histologically defined head and neck cancer.
• A diagnosis of head and neck lymphedema.
• Must be able and willing to participate in all aspects of the study and provide informed consent prior to study participation.
• Completed cancer treatment with no evidence of active cancer; all post-surgical swelling must be resolved.
• The head and neck garments must fit appropriately. For patients with a tracheostomy, the fit will be assessed to ensure that the garments do not interfere with their tracheostomy.
• The subject must have experienced at least one of the following:
• Completion of phase 1 lymphedema care in the past 8 weeks;
• The inability to participate/complete phase 1 care due to:
• Lack of available therapist/clinic,
• Lack of insurance coverage or funding to support cost of care.

Exclusion criteria

• Uncontrolled hyperthyroidism or parathyroidism (for which endocrinologist recommends against neck compression).
• Carotid sinus hypersensitivity syndrome.
• Symptomatic carotid artery disease, as manifested by a recent transient ischemic attack (within 30 days), ischemic stroke, or amaurosis fugax (monocular visual ischemic symptoms or blindness).
• Symptomatic bradycardia in the absence of a pacemaker.
• Internal jugular venous thrombosis, acute or within 3 months.
• Increased intracranial pressure or other contraindications to internal or external jugular venous compression.
• Acute radiation dermatitis, unhealed surgical scar, unhealed or open wound(s), surgical flap less than 6-8 weeks post-operative.
• Facial or head and neck dermal metastasis.
• Acute facial infection (e.g., facial or parotid gland abscess).
• Any condition in which increased venous and lymphatic return is undesirable.
• History of pulmonary edema or decompensated congestive heart failure with in six (6) week of enrollment.
• Subject is pregnant or trying to become pregnant.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

49 participants in 2 patient groups

Standard of Care

Active Comparator group

Description:

Standard home lymphedema care

Treatment:

Other: Standard home lymphedema care

Flexitouch head and neck lymphedema treatment system

Experimental group

Description:

Daily treatment with Flexitouch® pneumatic compression device for treatment of head and neck lymphedema and standard home lymphedema care

Treatment:

Device: Flexitouch head and neck lymphedema treatment system